Circ_USP36 Silencing Attenuates Oxidized Low-Density Lipoprotein-Induced Dysfunction in Endothelial Cells in

Yixin Zhang1, Wenhua Li2, Hui Li1

  • 1Department of Endocrinology, the Second Affiliated Hospital of Qiqihar Medical University, Qiqihar City, Heilongjiang, China; and.

Insights

Circular RNA USP36 (circ_USP36) exacerbates endothelial cell dysfunction in atherosclerosis. Inhibiting circ_USP36 protects against oxidized LDL effects by targeting the miR-197-3p/ROBO1 pathway, offering a potential therapeutic strategy.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Cell Biology

Background:

  • Circular RNAs (circRNAs) are increasingly recognized for their regulatory roles in cardiovascular diseases, including atherosclerosis.
  • Oxidized low-density lipoprotein (ox-LDL) is a key factor in endothelial cell (EC) dysfunction, a critical process in atherosclerosis development.
  • The specific role of circRNA ubiquitin-specific peptidase 36 (circ_USP36) in ox-LDL-induced EC dysfunction remains to be fully elucidated.

Purpose of the Study:

  • To investigate the biological role of circ_USP36 in oxidized low-density lipoprotein (ox-LDL)-induced dysfunction of human umbilical vein endothelial cells (HUVECs).
  • To elucidate the molecular mechanism underlying circ_USP36's function in this context, including its interaction with microRNA-197-3p (miR-197-3p) and roundabout guidance receptor 1 (ROBO1).

Main Methods:

  • Quantitative reverse transcription-polymerase chain reaction (RT-qPCR) and Western blot assays were used to measure RNA and protein levels.
  • Cell proliferation, cell cycle, apoptosis, and cell death were assessed using assays such as EdU, MTT, flow cytometry, and LDH.
  • Dual-luciferase reporter assays verified intermolecular interactions between circ_USP36, miR-197-3p, and ROBO1.

Main Results:

  • Circ_USP36 expression was significantly upregulated in atherosclerosis patients' serum and ox-LDL-stimulated HUVECs.
  • Knockdown of circ_USP36 ameliorated ox-LDL-induced inhibition of proliferation, cell cycle arrest, apoptosis, and inflammation in HUVECs.
  • Circ_USP36 targeted miR-197-3p, which in turn targeted ROBO1; circ_USP36 knockdown reduced ROBO1 expression by upregulating miR-197-3p.

Conclusions:

  • Circ_USP36 plays a detrimental role in ox-LDL-induced endothelial cell dysfunction.
  • Interference with circ_USP36 alleviates ox-LDL-induced HUVEC dysfunction by targeting the miR-197-3p/ROBO1 axis.
  • Circ_USP36 represents a potential therapeutic target for atherosclerosis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
77
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.4K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
806
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
16.8K